NCT06006923 2026-01-20Regorafenib in Combination With Pembrolizumab or Pembrolizumab for MSI-H Colorectal CancerUniversity of PittsburghPhase 2 Terminated1 enrolled
NCT05841134 2023-05-09Tislelizumab Combined With Chemotherapy (CAPOX) in the Perioperative Treatment of MSI-H/dMMR Stage II or III Colorectal CancerThe First Affiliated Hospital of Zhengzhou UniversityPhase 2 Not yet recruiting25 enrolled